Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.1100 (-3.72%) ($33.1100 - $33.1100) on Thu. May. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 45 | Latest Price | $33.1100(-3.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.4% a day on average for past five trading days. | Weekly Trend | HALO declines -2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(42%) IWO(39%) IWM(37%) XBI(35%) IBB(34%) | Factors Impacting HALO price | HALO will decline at least -1.64% in a week (0% probabilities). UUP(-16%) VXX(-14%) TBT(-11%) VIXM(-6%) BNDX(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $21.66(-34.58%) | 5 Day Moving Average | $31.86(3.92%) | 10 Day Moving Average | $31.92(3.73%) | 20 Day Moving Average | $33.01(0.3%) | To recent high | -34.3% | To recent low | 9.8% | Market Cap | $4.525b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |